Compare
CVS Health vs Veracyte (CVS vs VCYT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year CVS Health (CVS) returned +6.8% and Veracyte (VCYT) -47.5%; so far this year the figures are +5.7% and -42.6%.
CVS Health is the larger company by market value, about 55.0 times the size of Veracyte.
On trailing earnings, CVS trades at 9.7 times and VCYT at 15.7 times.
Revenue grew +6.7% at CVS and +17.5% at VCYT over the last year.
CVS yields 3.17%. VCYT pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| CVS | VCYT | |
|---|---|---|
| Price | $83.85 | $24.16 |
| 1-day | +3.10% | +0.67% |
| YTD | +5.66% | -42.61% |
| 1 year | +6.75% | -47.52% |
| 3 years | +22.00% | +14.72% |
| Market cap | $107.3B | $1.9B |
| P/E | 9.7 | 15.7 |
| P/S | 0.26 | 3.35 |
| P/B | 1.33 | 1.36 |
| Revenue growth | +6.70% | +17.50% |
| EPS growth | +2107.70% | +305.30% |
| Gross margin % | 44.2 | 72.0 |
| Net margin % | 2.6 | 21.8 |
| ROE % | 13.7 | 8.9 |
| Debt / equity | 0.75 | 0.00 |
| FCF yield % | 14.5 | 8.3 |
| Dividend yield % | 3.17 | — |
| Beta | -0.06 | 3.26 |
| RSI (14) | 39.9 | 24.8 |
| Technical rating |